Diversity in Dermatology Clinical Trials

DSpace/Manakin Repository

Diversity in Dermatology Clinical Trials

Citable link to this page


Title: Diversity in Dermatology Clinical Trials
Author: Charrow, Alexandra Phillippa; Xia, Fan; Joyce, Cara; Mostaghimi, Arash

Note: Order does not necessarily reflect citation order of authors.

Citation: Charrow, Alexandra, Fan Di Xia, Cara Joyce, and Arash Mostaghimi. 2017. “Diversity in Dermatology Clinical Trials.” JAMA Dermatology 153 (2) (February 1): 193. doi:10.1001/jamadermatol.2016.4129.
Full Text & Related Files:
Abstract: Question What is the racial, ethnic, and sex makeup of participants in randomized clinical trials of dermatologic conditions?

Findings In this systematic review of 626 trials conducted in 2010 through 2015, there was a low level of reporting of racial and ethnic composition of trial participants. Those US trials that reported race and ethnicity included a proportional number of women and African Americans compared with the general population, but Hispanic representation was lower than that of the general population of the United States.

Meaning While dermatologic clinical trials conducted in the United States are racially diverse, the field must increase reporting of race and ethnicity and strive for representative study cohorts especially with respect to ethnic diversity.
Published Version: doi:10.1001/jamadermatol.2016.4129
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33785927
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search